Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study
University of Edinburgh · Johns Hopkins University · +45 more institutions
Abstract
Seasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018.
We estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries.
Citation impact
- FWCI
- 39.18
- Percentile
- 100%
- References
- 54
Authors
193- XWXin WangCorresponding
University of Edinburgh
- YLYou Li
University of Edinburgh
- KLKatherine L. O’Brien
Johns Hopkins University
- SAShabir A. Madhi
University of the Witwatersrand, Respiratory and Meningeal Pathogens Research Unit, National Research Foundation
- MWMarc‐Alain Widdowson
Centers for Disease Control and Prevention, Instituut voor Tropische Geneeskunde
Topics & keywords
- Medicine
- Case fatality rate
- Incidence (geometry)
- Vaccination
- Virus
- Pediatrics
- Epidemiology
- Virology
- No poverty
Funding
- UDU.S. Department of Health and Human Services
- BABill and Melinda Gates FoundationAward: OPP 1172551
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- WHWorld Health Organization
- PPATH
- JAJapan Agency for Medical Research and DevelopmentAwards: U01-GH001003, U01-GH0000028, JP18fm0108001
- RPRegeneron Pharmaceuticals
- EFEuropean Federation of Pharmaceutical Industries and AssociationsAward: 116019
- NNovavax
- NINational Institute for Health and Care Research
- NRNational Research FoundationAward: 116019
- CSChina Scholarship Council
- BNBavarian Nordic
- SSeqirus
- NINational Institutes of Health
- CFCenters for Disease Control and Prevention
- SPSanofi Pasteur
- MRMedical Research Council
- H2Horizon 2020